The discovery of a new UCP-2 mediated resistant mechanism to paclitaxel and using nanoplatform to enhance cancer treatment
博士 === 國立成功大學 === 臨床醫學研究所 === 101 === Stat3 is more involved in tumor formation and Stat3 inhibition results in reduced cell viability and increased apoptosis in Non-Small Cell Lung Cancer (NSCLC). We have demonstrated that lung cancer cells with constitutive Stat3 activation are more resistant to p...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2012
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/98740700818594784979 |